Carnegie acted as sole global co-ordinator in the directed share issue in BICO Group to Sartorius of 6,408,626 B shares at a subscription price of SEK 76.00 per share. BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing. Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry and listed on the Frankfurt Stock Exchange.
December 2022.
Healthcare
Directed share issue in BICO Group AB (SE) to Sartorius AG (DE) — SEK 487 million
December 2022